Literature DB >> 22936279

Survey on vision-related quality of life and self-management among patients with glaucoma.

Peixia Wu1, Shuxin Xi, Haiou Xia, Huijuan Lu, Wenyi Guo.   

Abstract

PURPOSE: The aim of the study was to investigate the vision-related quality of life in glaucoma patients and identify the possible predictors for outcomes.
METHODS: A total sample of 167 subjects with glaucoma was recruited using a convenience sampling strategy. The National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) and the Glaucoma Self-Management Questionnaire were used for assessing vision-related quality of life and self-management behavior, respectively. The demographic and disease-related data were also collected.
RESULTS: Regarding the vision-related quality of life, the lowest scores were for general health (32.78±23.59), followed by general vision (46.35±19.52). The highest score was for the dimension of color vision (89.02±20.76). Multiple linear regression analysis demonstrated that self-management behavior, positive glaucoma family history, and binocular visual acuity were predictors of vision-related quality of life in this patient group.
CONCLUSIONS: The current study indicates that vision-related quality of life in glaucoma patients is at a moderate level in China. Self-management behavior is an important predictor. Demographic data may not increase the explanatory effect. Future research should focus on how to integrate self-management skills into routine nursing practice for patients with glaucoma.

Entities:  

Mesh:

Year:  2014        PMID: 22936279     DOI: 10.1097/IJG.0b013e318265bbf3

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  8 in total

1.  Provider use of collaborative goal setting with glaucoma patients.

Authors:  Betsy Sleath; Catherine Slota; Susan J Blalock; Robyn Sayner; Delesha M Carpenter; Kelly W Muir; Mary Elizabeth Hartnett; Alan L Robin
Journal:  Optom Vis Sci       Date:  2014-05       Impact factor: 1.973

2.  Vision-Related Quality of Life in Patients With Atypical Optic Neuritis.

Authors:  Zhaocai Jiang; Haiyan Qian; Shihui Wei
Journal:  Front Pain Res (Lausanne)       Date:  2022-05-12

3.  Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence.

Authors:  B Sleath; D M Carpenter; S J Blalock; R Sayner; K W Muir; C Slota; A L Giangiacomo; M E Hartnett; G Tudor; A L Robin
Journal:  Health Educ Res       Date:  2015-09-02

4.  Pilot Study of Clinician-Patient Collaboration in Glaucoma.

Authors:  Michael Smith; Marco Bresolin; Rose McCabe
Journal:  Clin Ophthalmol       Date:  2021-04-23

5.  Is glaucoma comprehension associated with psychological disturbance and vision-related quality of life for patients with glaucoma? A cross-sectional study.

Authors:  Xiang Mei Kong; Wen Qing Zhu; Jia Xu Hong; Xing Huai Sun
Journal:  BMJ Open       Date:  2014-05-26       Impact factor: 2.692

6.  Vision-related Quality of Life in Congolese Patients with Glaucoma.

Authors:  Isis K Kapinga; David L Kayembe; Jean-Claude Mwanza
Journal:  J Curr Glaucoma Pract       Date:  2022 Jan-Apr

7.  A randomized, controlled trial to test the effectiveness of a glaucoma patient navigator to improve appointment adherence.

Authors:  Lisa A Hark; Deiana M Johnson; Giuliana Berardi; Neal S Patel; Lichuan Zeng; Yang Dai; Eileen L Mayro; Michael Waisbourd; L Jay Katz
Journal:  Patient Prefer Adherence       Date:  2016-09-08       Impact factor: 2.711

8.  Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol.

Authors:  Anthony J King; Gordon Fernie; Augusto Azuara-Blanco; Jennifer M Burr; Ted Garway-Heath; John M Sparrow; Luke Vale; Jemma Hudson; Graeme MacLennan; Alison McDonald; Keith Barton; John Norrie
Journal:  Br J Ophthalmol       Date:  2017-10-26       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.